Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 12 of 12

Outcome	Group	Value	Spread	Units
Tumour Stabilisation Rate	ZD6474 300	5.3		percentage of patients
Tumour Stabilisation Rate	ZD6474 100	16.0		percentage of patients
Tumour Stabilisation Rate	Placebo	8.7		percentage of patients
Objective Response Rate	ZD6474 300	0		percentage of patients
Objective Response Rate	ZD6474 100	0		percentage of patients
Objective Response Rate	Placebo	0		percentage of patients
Progression-free Survival	ZD6474 300	32	95% Confidence Interval 29	Days
Progression-free Survival	ZD6474 100	53	95% Confidence Interval 29	Days
Progression-free Survival	Placebo	29	95% Confidence Interval 28	Days
Overall Survival	ZD6474 300	181	95% Confidence Interval 117 to 290	Days
Overall Survival	ZD6474 100	175	95% Confidence Interval 137 to 309	Days
Overall Survival	Placebo	130	95% Confidence Interval 93 to 180	Days

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00508001/results